182 related articles for article (PubMed ID: 35064733)
1. Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial.
Pijpers JA; Kies DA; van Zwet EW; Rosendaal FR; Terwindt GM
Eur J Neurol; 2022 May; 29(5):1496-1504. PubMed ID: 35064733
[TBL] [Abstract][Full Text] [Related]
2. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].
Artemenko AR; Abramov VG; Bozhenkina TV; Konovalova ZN; Korenko AN; Krasavina DA; Kurenkov AL; Latysheva NV; Naprienko MV; Orlova OR; Filatova EG; Shevchenko VS; Iakovleva PN
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):64-74. PubMed ID: 37994890
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
Bøe MG; Mygland A; Salvesen R
Neurology; 2007 Jul; 69(1):26-31. PubMed ID: 17475943
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).
Grazzi L; D'Amico D; Guastafierro E; Demichelis G; Erbetta A; Fedeli D; Nigri A; Ciusani E; Barbara C; Raggi A
J Headache Pain; 2023 Jul; 24(1):86. PubMed ID: 37452281
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.
Diener HC; Marmura MJ; Tepper SJ; Cowan R; Starling AJ; Diamond ML; Hirman J; Mehta L; Brevig T; Sperling B; Cady R
Headache; 2021 Jan; 61(1):125-136. PubMed ID: 33314079
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial.
Carlsen LN; Munksgaard SB; Nielsen M; Engelstoft IMS; Westergaard ML; Bendtsen L; Jensen RH
JAMA Neurol; 2020 Sep; 77(9):1069-1078. PubMed ID: 32453406
[TBL] [Abstract][Full Text] [Related]
10. Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.
Cevoli S; Giannini G; Favoni V; Terlizzi R; Sancisi E; Nicodemo M; Zanigni S; Bacchi Reggiani ML; Pierangeli G; Cortelli P
J Headache Pain; 2017 Dec; 18(1):56. PubMed ID: 28500492
[TBL] [Abstract][Full Text] [Related]
11. Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.
Schwedt TJ; Hentz JG; Sahai-Srivastava S; Murinova N; Spare NM; Treppendahl C; Martin VT; Birlea M; Digre K; Watson D; Leonard M; Robert T; Dodick DW;
Neurology; 2022 Apr; 98(14):e1409-e1421. PubMed ID: 35169011
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib vs prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial.
Taghdiri F; Togha M; Razeghi Jahromi S; Paknejad SM
Headache; 2015 Jan; 55(1):128-35. PubMed ID: 25600720
[TBL] [Abstract][Full Text] [Related]
13. Treatment of medication overuse headache: Effect and predictors after 1 year-A randomized controlled trial.
Carlsen LN; Rouw C; Westergaard ML; Nielsen M; Munksgaard SB; Bendtsen L; Jensen RH
Headache; 2021 Jul; 61(7):1112-1122. PubMed ID: 34325483
[TBL] [Abstract][Full Text] [Related]
14. Alterations in DNA methylation associate with reduced migraine and headache days after medication withdrawal treatment in chronic migraine patients: a longitudinal study.
Mehta D; de Boer I; Sutherland HG; Pijpers JA; Bron C; Bainomugisa C; Haupt LM; van den Maagdenberg AMJM; Griffiths LR; Nyholt DR; Terwindt GM
Clin Epigenetics; 2023 Dec; 15(1):190. PubMed ID: 38087366
[TBL] [Abstract][Full Text] [Related]
15. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
Negro A; Curto M; Lionetto L; Martelletti P
J Headache Pain; 2015; 17():1. PubMed ID: 26792662
[TBL] [Abstract][Full Text] [Related]
16. No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse: A double blind, randomised clinical trial.
Grazzi L; Usai S; Bolognini N; Grignani E; Sansone E; Tramacere I; Maravita A; Lauria G
Cephalalgia; 2020 Oct; 40(11):1202-1211. PubMed ID: 32536270
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
Freitag FG; Diamond S; Diamond M; Urban G
Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
Silberstein SD; Blumenfeld AM; Cady RK; Turner IM; Lipton RB; Diener HC; Aurora SK; Sirimanne M; DeGryse RE; Turkel CC; Dodick DW
J Neurol Sci; 2013 Aug; 331(1-2):48-56. PubMed ID: 23790235
[TBL] [Abstract][Full Text] [Related]
19. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial.
Engelstoft IMS; Carlsen LN; Munksgaard SB; Nielsen M; Jensen RH; Bendtsen L
Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412
[TBL] [Abstract][Full Text] [Related]
20. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study.
Rabe K; Pageler L; Gaul C; Lampl C; Kraya T; Foerderreuther S; Diener HC; Katsarava Z
Cephalalgia; 2013 Feb; 33(3):202-7. PubMed ID: 23093541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
